Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?

ConclusionsIn this retrospective hypothesis-generating analysis, less vs. more than 5 weeks OTT may increase acute and late GU toxicities without significantly improving bRFS in patients treated to high effective doses (> 80 Gy) with moderate hypofractionated RT. Prospective trials evaluating the impact of OTT on hypofractionated schedules for PCa are warranted.

http://link.springer.com/10.1007/s00432-019-02893-4

Source: Journal of Cancer Research and Clinical Oncology - March 17, 2019 Category: Cancer & Oncology Source Type: research